EXACT SCIENCES CORP (EXAS)

US30063P1057 - Common Stock

57.53  -1.96 (-3.29%)

After market: 57.53 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

EXACT SCIENCES CORP

NASDAQ:EXAS (2/23/2024, 7:00:01 PM)

After market: 57.53 0 (0%)

57.53

-1.96 (-3.29%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap10.40B
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

EXAS Daily chart

Company Profile

EXACT Sciences Corp. is a cancer screening and diagnostics company. The company is headquartered in Madison, Wisconsin and currently employs 6,300 full-time employees. The company went IPO on 2001-01-30. The firm provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The firm is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Company’s products include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test and COVID-19 Testing. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.

Company Info

EXACT SCIENCES CORP

5505 Endeavor Lane

Madison WISCONSIN 53719

P: 16082845700

CEO: Kevin T. Conroy

Employees: 6300

Website: https://www.exactsciences.com/

EXAS News

News Image4 days ago - The Motley FoolExact Sciences (EXAS) Q4 2023 Earnings Call Transcript

EXAS earnings call for the period ending December 31, 2023.

News Image4 days ago - Seeking AlphaExact Sciences GAAP EPS of -$0.27 beats by $0.21, revenue of $647M beats by $7.3M (NASDAQ:EXAS)

Exact Sciences beats expectations with Q4 earnings. Revenue of $647M, a 17% increase.

News Image4 days ago - Exact Sciences Corp.Exact Sciences Announces Fourth Quarter 2023 Results
News Image4 days ago - Market News VideoNotable Wednesday Option Activity: EXAS, S, PUBM
News Image18 days ago - Market News VideoEXACT Sciences Larger Than S&P 500 Component AES
News Image18 days ago - The Motley FoolCathie Wood Is Selling This Stock: Should You?

This company hasn't performed well in the past 12 months.

EXAS Twits

Here you can normally see the latest stock twits on EXAS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example